Delyon, J., Resche-Rigon, M., Renaud, M., Le Goff, J., Dalle, S., Heidelberger, V., . . . Lebbé, C. (2020). 1077MO PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: A multicenter phase II study. Annals of Oncology, 31, S732. https://doi.org/10.1016/j.annonc.2020.08.1201
Chicago Style (17th ed.) CitationDelyon, J., et al. "1077MO PD1 Blockade with Pembrolizumab in Classic and Endemic Kaposi Sarcoma: A Multicenter Phase II Study." Annals of Oncology 31 (2020): S732. https://doi.org/10.1016/j.annonc.2020.08.1201.
MLA (9th ed.) CitationDelyon, J., et al. "1077MO PD1 Blockade with Pembrolizumab in Classic and Endemic Kaposi Sarcoma: A Multicenter Phase II Study." Annals of Oncology, vol. 31, 2020, p. S732, https://doi.org/10.1016/j.annonc.2020.08.1201.